Rankings
▼
Calendar
BMRN Q1 2016 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$237M
Gross Profit
$194M
81.8% margin
Operating Income
-$81M
-34.2% margin
Net Income
-$83M
-35.1% margin
EPS (Diluted)
$-0.53
Cash Flow
Operating Cash Flow
-$172M
Free Cash Flow
-$217M
Stock-Based Comp.
$30M
Balance Sheet
Total Assets
$3.7B
Total Liabilities
$1.4B
Stockholders' Equity
$2.3B
Cash & Equivalents
$270M
Revenue Segments
Product Three
$77M
33%
Product One
$73M
31%
Product Two
$65M
28%
Product Four
$16M
7%
Product Five
$4M
2%
Geographic Segments
UNITED STATES
$110M
46%
Europe
$63M
27%
Rest Of World
$46M
19%
Latin America
$18M
8%
← FY 2016
All Quarters
Q2 2016 →
